The CTRC-AACR San Antonio Breast Cancer Symposium, Dec. 9-13, 2009, attracts world leaders in cancer research and treatment, including clinical oncologists, industry leaders, basic scientists and translational researchers who are working to improve patient care with the ultimate goal of eradicating breast cancer.
Watch James Ingle, M.D., Professor of Oncology at the Mayo Clinic, talk about "A genome-wide association study in patients experiencing musculoskeletal adverse events on aromatase inhibitors as adjuvant therapy in early breast cancer entered on NCIC CTG Trial MA.27."
Download the video (68 MB file; 5:44 duration. Requires QuickTime to view).
Subscribe to the AACR Scientific Podcast feed through the following:
Subscribe to the AACR Scientific Podcast via a RSS Reader
Also, follow AACR throughout the meeting on Twitter @AACR, using the hash tag #SABCS09.
Subscribe to the AACR RSS News Feed.
Updated: Dec. 10, 2009